RxDoctor Payments Data
★ My doctorsLook up a doctor →

Adrian Jaffer

la Jolla, CANPI 1366476152

Payments from drug & device makers

$3,327in general payments, 2019–2025

Across 152 payments — averaging $21.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$403
  • GSK$385
  • AstraZeneca$359
  • Amgen$256
  • AbbVie$225
  • Genentech USA, Inc.$204
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$3,293100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Regeneron Healthcare Solutions, Inc.11$403
GSK17$385
AstraZeneca19$359
Amgen14$256
AbbVie10$225
Genentech USA, Inc.11$204
Pfizer8$186
Kaleo, Inc.7$123
Boehringer Ingelheim5$123
Novartis5$114
UCB, Inc.3$104
Johnson & Johnson(2 entities)4$100
Shire North American Group Inc5$85
Medexus Pharma, Inc.5$85
Lilly USA, LLC4$84
Sanofi4$80
Teva Pharmaceuticals USA, Inc.4$74
Bristol Myers Squibb2$45
E.r. Squibb & Sons, L.L.C.2$42
Sanofi-aventis U.S. LLC2$38
Sobi, Inc2$36
CSL Behring2$36
Alk-abello, Inc2$35
Eli Lilly1$34
Pacira Therapeutics, Inc.1$26
Mallinckrodt Enterprises LLC1$22
Optinose US, Inc.1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →